Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M McNagny

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Blood|October 24, 2002
E26 leukemia virus converts primitive erythroid cells into cycling multilineage progenitorsKelly M McNagny, Thomas Graf
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2014
Preface. Mast cellsMichael R Hughes, Kelly M McNagny
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 13, 2010
Stem cells, inflammation and allergyMarie-Renee Blanchet, Kelly M McNagny
Journal of the American Society of Nephrology : JASN|July 7, 2009
The role of podocalyxin in health and diseaseJulie S Nielsen, Kelly M McNagny
Journal of Cell Science|November 7, 2008
Novel functions of the CD34 familyJulie S Nielsen, Kelly M McNagny
Blood|July 24, 2007
Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cellsJulie S Nielsen, Kelly M McNagny
Frontiers in Immunology|May 24, 2021
ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell DevelopmentSamuel B Shin, Kelly M McNagny
Microcirculation (New York, N.Y. : 1994)|May 30, 2009
CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the peripheryJulie S Nielsen, Kelly M McNagny
Clinical and Experimental Immunology|June 16, 2023
Unconventional T cells in chronic disease and as targets of therapySamuel B Shin, Kelly M McNagny
Biochimica Et Biophysica Acta|February 24, 2009
Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulationSteven Maltby, Khashayarsha Khazaie, Kelly M McNagny
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Blood|October 24, 2002
E26 leukemia virus converts primitive erythroid cells into cycling multilineage progenitorsKelly M McNagny, Thomas Graf
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2014
Preface. Mast cellsMichael R Hughes, Kelly M McNagny
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 13, 2010
Stem cells, inflammation and allergyMarie-Renee Blanchet, Kelly M McNagny
Journal of the American Society of Nephrology : JASN|July 7, 2009
The role of podocalyxin in health and diseaseJulie S Nielsen, Kelly M McNagny
Journal of Cell Science|November 7, 2008
Novel functions of the CD34 familyJulie S Nielsen, Kelly M McNagny
Blood|July 24, 2007
Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cellsJulie S Nielsen, Kelly M McNagny
Frontiers in Immunology|May 24, 2021
ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell DevelopmentSamuel B Shin, Kelly M McNagny
Microcirculation (New York, N.Y. : 1994)|May 30, 2009
CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the peripheryJulie S Nielsen, Kelly M McNagny
Clinical and Experimental Immunology|June 16, 2023
Unconventional T cells in chronic disease and as targets of therapySamuel B Shin, Kelly M McNagny
Biochimica Et Biophysica Acta|February 24, 2009
Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulationSteven Maltby, Khashayarsha Khazaie, Kelly M McNagny
Pageof 14